Labiana Health (XMAD:LAB) EV-to-EBIT : -9.19 (As of Jun. 05, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Labiana Health's Enterprise Value is €52.70 Mil. Labiana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-5.73 Mil. Therefore, Labiana Health's EV-to-EBIT for today is -9.19.

The historical rank and industry rank for Labiana Health's EV-to-EBIT or its related term are showing as below:

XMAD:LAB's EV-to-EBIT is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.495
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Labiana Health's Enterprise Value for the quarter that ended in Dec. 2022 was €59.79 Mil. Labiana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-5.73 Mil. Labiana Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -9.59%.

Labiana Health EV-to-EBIT Historical Data

The historical data trend for Labiana Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health EV-to-EBIT Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

EV-to-EBIT

-10.43

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
EV-to-EBIT	-	-	-	-10.43

Competitive Comparison of Labiana Health's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Labiana Health's EV-to-EBIT falls into.

Labiana Health EV-to-EBIT Calculation

Labiana Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	52.695	/	-5.733
	=	-9.19

Labiana Health's current Enterprise Value is €52.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labiana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-5.73 Mil.

Labiana Health (XMAD:LAB) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Labiana Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2022 )	=	EBIT	/	Enterprise Value (Q: Dec. 2022 )
	=	-5.733	/	59.7884336
	=	-9.59 %

Labiana Health's Enterprise Value for the quarter that ended in Dec. 2022 was €59.79 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labiana Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €-5.73 Mil.

Labiana Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Labiana Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » EV-to-EBIT

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.